Co-Diagnostics, Inc. (CODX) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

Co-Diagnostics, Inc. (CODX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $6.7M, listed on NASDAQ, employing roughly 115 people, carrying a beta of 2.90 to the broader market. Co-Diagnostics, Inc. Led by Dwight Egan, public since 2017-07-12.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for CODX as of 2026-10-15; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →